$DOX

Amdocs (DOX) Q4 2026 Earnings Call Transcript

Amdocs (DOX) announced an 8-year deal with AT&T and other strategic agreements with VEON, Globe, and VodafoneThree to adopt its AOS technology. The company also acquired EIS, an insurance software provider, for $340M. Amdocs plans to expand into the insurance market and has optimized its portfolio to focus on its agentic strategy. The company reported progress in internal transformation and provided FY2027 revenue growth guidance.

Original reporting
Published Nov 4, 2026, 3:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 3:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Amdocs (DOX) Q4 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$DOXBullishHigh
01

Why it matters

The announcements collectively expand Amdocs' addressable market and could drive near‑term stock appreciation, while partners like VEON may see incremental revenue growth.

02

Market read

Primary corporate news with material M&A and new contracts; high relevance for traders focused on telecom software and AI integration themes.

03

What to watch

Potential regulatory scrutiny of the large AI‑focused deal and execution risk in new insurance vertical.

Relevance 9/10Novelty 9/10Timing: today

Background

Amdocs' Q4 2026 earnings call introduced several multi‑year contracts and a strategic acquisition, signaling a shift toward AI‑enabled services across telecom and insurance.

Company-level read

Ticker impact

$DOXBullishHigh confidence
Context

Amdocs announced a $340 million cash acquisition of EIS and multiple new strategic agreements, marking a major expansion.

Expected impact

likely upside as investors value the growth opportunity

Evidence & confidence

The acquisition adds a new vertical and sizable revenue potential, which should lift the stock.

$VEONBullishMedium confidence
Context

Amdocs signed a 10‑year strategic agreement with VEON to modernize its operations.

Expected impact

potential modest upside from expected revenue uplift

Evidence & confidence

The long‑term deal signals recurring revenue, but the effect is secondary to Amdocs' own news.

Market effects

Strengthens the telecom‑software sector and highlights AI‑driven service demand.

Boosts sentiment for US‑listed telecom software firms and European operators involved.

Shows growing convergence of AI and telecom worldwide, potentially influencing related stocks.

Counterpoint

The acquisition could strain Amdocs' balance sheet and integration risk may outweigh upside.

Key entities

  • Amdocs Ltd.

    US‑listed telecom software provider (ticker DOX).

  • VEON Ltd.

    Global digital operator (ticker VEON).

Related articles

$DOXMedAI 8/10

Amdocs share price tanks as T-Mobile US dispute weighs heavily

Amdocs' share price dropped 42% after reporting a 3.6% revenue rise to $4.7bn, due to a contract dispute with T-Mobile US. The dispute may lead to arbitration or legal action, and Amdocs expects a 7-11% revenue decline in the coming year. Despite this, Amdocs secured new contracts with Vodafone, AT&T, and others, and acquired EIS for $340m to expand into insurance technology.

$DOXHighAI 9/10

Amdocs drama: Stock crashes 45%

Amdocs' stock fell 45% after hours due to a weak 2027 forecast tied to a legal dispute with T-Mobile. The company reported a 9.6% drop in its 12-month order backlog to $3.5B and annual revenue of $4.7B, up 3.5%. Amdocs also announced a new contract with AT&T and acquired EIS for $340M to expand into insurance.

$DOXHighAI 9/10

Why is Amdocs stock cratering 40% today?

Amdocs stock fell 39.4% to $37.83 after issuing a weak fiscal 2027 outlook due to a legal dispute with T-Mobile, its largest customer. Q4 2026 results met expectations, but FY2027 revenue is projected to decline 14.3%-17.9% and adjusted EPS to fall 26%-30%. Oppenheimer downgraded the stock, and analysts revised earnings forecasts downward. The company also announced a $340M acquisition, adding to financial pressures.

$DOXHighAI 9/10

Why is Amdocs stock plummeting today?

Amdocs (DOX) stock fell 44.5% after-hours due to a fiscal 2027 outlook that missed expectations, citing a legal dispute with T-Mobile. Q4 2026 results met expectations, but Q1 2027 revenue guidance was 19% below consensus, and full-year EPS is projected to decline 26-30%. Oppenheimer downgraded the stock, and multiple analysts cut earnings estimates. The company is also exiting non-strategic businesses, adding to revenue uncertainty.